Directory of sitesLoginContactSupport
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

株式会社アイロムグループ

2372.T

現在値

1,881.00JPY

変化

23.00(+1.24%)

出来高

80,200

本日のレンジ

1,833.00

 - 

1,881.00

52週レンジ

1,695.00

 - 

2,751.00

∙ 約20分前の相場を表示しています。

適時開示

I'rom Group Co Ltd Says To Buy Back Up To 1.12 Percent Of Own Shares Worth 200 Million Yen Through March 29

I'rom Group Co Ltd <2372.T>::I'ROM GROUP CO LTD SAYS TO BUY BACK UP TO 1.12 PERCENT OF OWN SHARES WORTH 200 MILLION YEN THROUGH MARCH 29.

I'rom Group unit signs license agreement with Censo Biotechnologies

Oct 30 (Reuters) - I'rom Group Co Ltd <2372.T>:Says its unit ID Pharma Co., Ltd. signed license agreement with the United Kingdom-based firm Censo Biotechnologies Ltd related iPS cell technology .

I'rom Group unit concludes iPS cell generation technology licensing agreement with UK-based Elpis Biomed

Aug 22(Reuters) - I'rom Group Co Ltd <2372.T>:Says its wholly owned unit ID Pharma concluded an iPS cell generation technology licensing agreement with UK-based Elpis Biomed Limited.Under this agreement, Elpis Biomed Limited will pay up-front payment and royalties to ID Pharma .

I'rom Group signs partnership agreement with China co Beroni Group

Aug 21 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it signed partnership agreement with China company Beroni Group Limited on new business in cell culture and processing fields .

I'rom Group signs cooperation agreement with DENDRIX on advanced medical business

May 28 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it signs cooperation agreement with DENDRIX Inc. on advanced medical business .Says they will mainly cooperate on cell processing center related contract manufacturing and cell processing technology development .

I'rom Group unit concludes iPS cell generation technology licensing agreement with Evotec International GmbH

May 16 (Reuters) - I'rom Group Co Ltd <2372.T>:Says its unit ID Pharma Co., Ltd. concluded an iPS cell generation technology related licensing agreement with Germany company Evotec International GmbH .Says its unit will receive upfront payment and annual royalty from Evotec International GmbH .

I'rom Group unit ID Pharma signs iPS cell generation technology licensing agreement with U.S.-based QurAlis

Feb 2(Reuters) - I'rom Group Co Ltd <2372.T>:Says its wholly owned unit ID Pharma concluded an iPS cell generation technology licensing agreement with U.S.-based QurAlis Corporation.

I'rom Group to set up unit in Hong Kong to management and support co's business in China

Jan 29 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it will set up a Hong Kong-based wholly owned unit, I’ROM LIMITED in February, to management and support the company's business in China .Says the unit will be capitalized at HK$100,000 (about 1.5 million yen).

I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences

Jan 9 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co's wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc.

I'rom Group says business and capital alliance with OKWAVE unit

Oct 17 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co signs business and capital alliance agreement with OKWAVE <<<3808.NG>>> unit OKEIOS, which is mainly engaged in medical information handling systems related design, development and sales .Says co plans to acquire shares of OKEIOS.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up